acut
respiratori
infect
second
caus
morbid
mortal
children
adult
worldwid
virus
bacteria
fungi
involv
aetiolog
rapid
diagnosi
allow
better
clinic
manag
patient
adopt
public
health
measur
control
possibl
outbreak
main
etiolog
agent
diagnos
within
first
hour
onset
symptom
antigen
detect
techniqu
primarili
immunochromatographi
result
obtain
min
sensit
specif
diagnosi
streptococcu
pneumonia
legionella
pneumophila
serogroup
infect
urin
streptococcu
pyogen
throat
swab
respiratori
syncyti
viru
nasopharyng
aspir
wors
result
obtain
influenza
virus
pneumocysti
jirovecii
techniqu
howev
easytoperform
molecular
techniqu
avail
rapid
diagnosi
microorgan
gener
techniqu
use
monitor
outcom
respons
treatment
jm
r
e
u
e
n
la
infeccion
respiratoria
aguda
son
la
segunda
causa
de
morbimortalidad
tanto
en
como
adulto
nivel
mundial
en
cuya
se
implican
viru
bacteria
hongo
su
permit
un
mejor
manejo
del
pacient
adoptar
medida
de
salud
controlar
posibl
brote
lo
principal
microorganismo
respons
pueden
diagnosticars
en
la
primera
hora
tra
el
inicio
del
cuadro
con
de
de
fundamentalment
se
obtienen
resultado
en
min
con
una
sensibilidad
del
especificidad
superior
al
para
el
de
infeccion
por
streptococcu
pneumonia
legionella
pneumophila
serogrupo
partir
de
orina
streptococcu
pyogen
en
exudado
viru
respiratorio
sinciti
en
aspirado
en
infeccion
por
lo
viru
de
la
gripe
por
pneumocysti
jirovecii
lo
resultado
con
esta
son
peor
obstant
existen
molecular
de
para
el
de
esto
microorganismo
en
gener
esta
deben
utilizars
para
control
evolutivo
ni
para
valorar
respuesta
al
tratamiento
respiratori
tract
infect
one
primari
caus
morbid
mortal
one
principl
reason
medic
consult
world
infecti
process
swift
accur
diagnosi
associ
target
effect
treatment
lower
transmiss
diseas
often
reduct
durat
aim
studi
provid
review
rapid
diagnost
test
rdt
common
respiratori
infect
ri
chronic
evolut
ri
tuberculosi
affect
patient
specif
situat
eg
pneumonia
associ
respiratori
support
exclud
address
chapter
rdt
consid
whose
result
given
h
standard
work
shift
comparison
convent
bacteri
viral
cultur
techniqu
h
h
respect
even
though
serolog
antibodi
detect
techniqu
meet
tempor
definit
includ
given
demonstr
seroconvers
appear
antibodi
serum
seroreinforc
increas
initi
titr
antibodi
factor
may
take
week
month
come
high
level
variabl
individu
given
simplic
swift
implement
result
obtain
interpret
rdt
may
also
use
pointof
care
test
poct
subsequ
benefit
patient
may
receiv
diagnosi
depend
result
treatment
one
singl
consult
gener
use
rdt
diagnosi
ri
help
reduc
use
antibiot
given
mani
ri
viral
aetiolog
ensur
use
suitabl
antivir
therapi
specif
case
minimis
use
unnecessari
diagnost
test
reduc
length
hospit
stay
permit
swift
implement
isol
measur
limit
nosocomi
infect
whenev
necessari
moreov
ri
bacteri
origin
detect
antigen
target
pathogen
nucleic
acid
rdt
affect
much
lesser
extent
cultur
diagnosi
event
antibiot
treatment
alreadi
commenc
rdt
group
streptococcu
ga
fundament
aim
determin
bacteri
natur
pharyng
pharyng
common
infect
caus
gass
may
accompani
suppur
sequela
eg
peritonsillar
abscess
nonsuppur
sequela
eg
rheumat
fever
acut
glomerulonephr
although
nowaday
complic
rare
major
develop
countri
less
frequent
may
also
lead
seriou
infect
necrotis
fasciiti
infect
pneumonia
endocard
mening
major
paediatr
pharyng
particularli
children
year
age
caus
virus
whose
symptomatolog
similar
streptococc
infect
estim
case
pharyng
children
adult
due
ga
thu
low
percentag
patient
benefit
treatment
antibiot
explain
rdt
diagnosi
minor
ill
among
regularli
use
continu
assess
sinc
help
prevent
inappropri
use
antibiot
goldstandard
test
diagnosi
gasinduc
pharyng
continu
bacteri
cultur
blood
agar
either
direct
enrich
select
plate
incub
h
rdt
detect
ga
antigen
pharyng
swab
appear
begin
sinc
number
gener
rdt
employ
differ
methodolog
initi
techniqu
employ
latex
agglutin
follow
elisa
later
flow
test
colorimetr
immunochromatograph
test
recent
molecular
test
dna
probe
pcr
situ
fluoresc
hybridis
market
immunochromatograph
test
ict
current
among
frequent
use
rdt
owe
eas
use
rapid
result
min
great
mani
test
market
detect
c
carbohydr
ga
cell
wall
mean
specif
monoclon
polyclon
antibodi
major
test
carbohydr
must
extract
cell
wall
beforehand
acid
medium
capabl
dissolv
subsequ
detect
immunochromatograph
strip
optimum
perform
test
attain
popul
previous
screen
basi
certain
pharyng
infect
clinic
criteria
compar
cultur
refer
method
metaanalys
studi
perform
ga
rdt
pharynx
give
mean
sensit
vari
specif
around
gener
speak
sensit
vari
greatli
studi
specif
usual
high
rel
low
sensit
mean
major
author
continu
recommend
take
cultur
case
test
neg
order
detect
greater
number
case
great
advantag
ict
perform
presenc
patient
along
high
specif
mean
posit
result
confirmatori
cultur
requir
specif
antibodi
treatment
recommend
spot
except
special
circumst
perform
rdt
control
cultur
end
treatment
recommend
despit
advantag
offer
rdt
rememb
cultur
isol
ga
facilit
subsequ
perform
test
antibiot
sensit
test
genotyp
characteris
isol
also
rememb
even
though
role
subject
debat
low
percentag
bacteri
pharyng
betahaemolyt
streptococci
group
group
c
g
isol
detect
mean
ga
rdt
sinc
composit
carbohydr
cell
wall
differ
also
commerci
molecular
rdt
diagnosi
gasinduc
pharyng
infect
hybridis
realtim
pcr
although
sensit
specif
high
higher
cultur
method
limit
detect
exce
antigen
detect
techniqu
still
techniqu
take
one
two
hour
perform
need
qualifi
staff
specif
molecular
biolog
equip
along
simplic
sound
diagnost
perform
rdt
ict
antigen
meant
current
clinic
laboratori
routin
use
molecular
techniqu
rdt
gasinduc
pharyng
invas
infect
caus
ga
perform
rdt
also
compar
cultur
sensit
ict
antigen
detect
test
similar
pcr
greater
cultur
despit
test
recommend
presenc
antibiot
treatment
rdt
may
posit
sampl
neg
cultur
sinc
take
longer
becom
neg
legionella
group
bacteria
ubiquit
aquat
habitat
compris
speci
serogroup
exposur
aerosol
contain
legionella
give
rise
differ
clinic
manifest
legionnair
diseas
sever
communityacquir
pneumonia
pontiac
fever
selflimit
febril
syndrom
even
asymptomat
infect
pneumonia
import
owe
frequenc
account
around
communityacquir
pneumonia
cap
sever
ill
need
specif
treatment
macrolid
fluoroquinolon
antibiot
although
thought
speci
legionella
caus
ill
human
half
serogroup
isol
clinic
sampl
vast
major
legionellainduc
pneumonia
caus
l
pneumophila
serogroup
difficulti
slow
grow
legionella
specif
cultur
media
time
requir
seroconvers
serolog
diagnosi
meant
major
diagnost
test
regularli
use
diagnosi
pneumonia
caus
l
pneumophila
rdt
distinguish
use
antibodi
use
nucleic
acid
amplif
test
essenti
pcr
first
rdt
legionellosi
direct
immunofluoresc
dif
respiratori
sampl
use
specif
serogroup
antibodi
mark
fluorescein
dif
consid
rdt
sinc
perform
around
hour
rel
low
sensit
owe
displac
legionella
urin
antigen
detect
test
legionella
antigen
urin
detect
day
onset
symptom
month
infect
cure
although
major
case
becom
neg
one
two
month
onset
diseas
differ
method
detect
legionella
antigen
urin
enzym
immunoassay
plate
eia
enzymelink
immunosorb
assay
elisa
rapid
ict
either
card
strip
format
also
known
later
flow
test
ict
elisa
demonstr
sensit
around
specif
depend
studi
major
commerci
test
detect
l
pneumophila
serogroup
urinari
antigen
although
crossreact
serogroup
may
occur
impli
pneumonia
caus
speci
legionella
legionella
micdadei
legionella
bozemanii
etc
serogroup
although
much
less
frequent
normal
diagnos
use
test
also
test
detect
serogroup
speci
sensit
specif
characterist
lower
l
pneumophila
serogroup
test
detect
legionella
urinari
antigen
concentr
antigen
filter
enhanc
sensit
hand
boil
urin
enhanc
specif
sinc
reduc
nonspecif
interact
nonetheless
improv
rapid
test
increas
time
workload
result
obtain
ict
test
detect
l
pneumophila
serogroup
urinari
antigen
consid
poct
sinc
qualit
result
obtain
minut
without
need
specialis
personnel
take
sampl
perform
test
fluoresc
ict
test
recent
emerg
provid
greater
sensit
detect
elimin
possibl
bia
attribut
visual
read
result
lower
specif
observ
particularli
concentr
urin
improv
repeat
posit
test
boil
urin
eia
somewhat
slower
quantit
gener
use
clinic
laboratori
analys
larg
number
sampl
case
despit
poorer
cost
effect
import
perform
cultur
attempt
isol
microorgan
subsequ
epidemiolog
microbiolog
studi
market
nucleic
acid
amplif
rdt
includ
isotherm
amplif
convent
pcr
realtim
pcr
respiratori
sampl
lower
respiratori
tract
bronchoalveolar
sputum
aspir
lavag
etc
high
level
sensit
specif
benefit
use
includ
rapid
respons
time
current
widespread
use
clinic
microbiolog
laboratori
unlik
cultur
seroconvers
detect
urinari
antigen
posit
pcr
still
consid
basi
confirm
legionella
infect
must
interpret
caution
legionella
gene
amplifi
major
molecular
techniqu
gene
encod
ribosom
rna
subunit
spacer
region
macrophag
inhibitori
protein
mip
gene
suitabl
probe
also
possibl
detect
distinguish
l
pneumophila
speci
legionella
nucleic
acid
amplif
test
shown
greater
sensit
urinari
antigen
test
detect
pneumonia
caus
legionella
well
high
specif
pneumonia
undoubtedli
pathogen
frequent
caus
cap
particularli
seriou
form
bacteraemia
patient
life
risk
unlik
legionella
presenc
pneumonia
pneumococcu
respiratori
sampl
alway
indic
infect
sinc
also
known
colonis
upper
respiratori
tract
complic
interpret
diagnosi
detect
pneumococcu
antigen
urin
one
avail
rdt
test
detect
presenc
urin
cpolysaccharid
pneumococcu
cell
wall
antigen
common
almost
differ
serotyp
pneumococcu
describ
date
relat
speci
streptococcu
miti
streptococcu
orali
first
test
describ
number
differ
techniqu
tri
detect
latex
agglutin
coagglutin
enzym
immunoassay
howev
result
promis
abandon
emerg
ict
test
reliabl
result
lead
reawaken
interest
detect
sensit
urinari
antigen
diagnosi
pneumococc
pneumonia
mean
ict
vari
greatli
depend
studi
owe
lack
goldstandard
unequivoc
establish
aetiolog
pneumonia
sensit
normal
vari
gener
higher
bacteraem
pneumococc
pneumonia
studi
specif
also
vari
accord
studi
gener
result
higher
homogen
rang
posit
result
must
interpret
caution
sinc
may
reflect
asymptomat
colonis
particularli
children
perform
test
recommend
children
tend
nasopharyng
carrier
addit
test
may
posit
month
pneumococc
infect
howev
detect
antigen
urin
unlik
cultur
practic
unaffect
prior
antibiot
treatment
recent
test
detect
urin
capsular
pneumococc
polysaccharid
pneumonia
caus
serotyp
use
luminex
technolog
develop
although
sensit
seem
greater
detect
cpolysaccharid
still
commerci
avail
test
show
correspond
cpolysaccharid
detect
test
would
seem
sensit
altern
serotyp
incorpor
detect
rdt
includ
detect
pneumonia
dna
pcr
high
sensit
test
along
possibl
colonis
pathogen
make
interpret
posit
result
difficult
promin
among
gene
use
detect
pneumonia
autolysin
gene
lyta
pneumolysin
gene
pli
attempt
made
quantifi
pneumonia
load
realtim
pcr
respiratori
sampl
order
distinguish
colonis
infect
despit
standard
criteria
establish
distinguish
clinic
situat
addit
diagnosi
pneumonia
rdt
pneumococcu
also
use
detect
pathogen
steril
sampl
csf
mening
pleural
liquid
parapneumon
effus
detect
pneumococc
antigen
ict
steril
sampl
shown
sensit
cultur
still
detect
presenc
antibiot
treatment
hand
pneumococcu
detect
mean
pcr
steril
sampl
use
success
given
presenc
sampl
unlik
respiratori
sampl
constitut
diagnosi
infect
rememb
despit
advantag
rdt
diagnosi
pneumococc
infect
must
supplement
rather
replac
blood
cultur
sputum
cultur
make
possibl
isol
causal
microorgan
ascertain
antibiot
suscept
well
microbiolog
characterist
serotyp
genotyp
etc
great
valu
handl
control
infect
acut
ri
viral
aetiolog
constitut
whole
one
infecti
clinic
syndrom
affect
human
children
cap
case
bronchiol
approxim
asthma
attack
associ
infect
respiratori
virus
rv
adult
rv
detect
cap
asthma
attack
copd
attack
around
twenti
virus
implic
aetiolog
agent
process
import
owe
clinic
epidemiolog
relev
influenza
b
virus
respiratori
syncyti
viru
rsv
lesser
extent
adenoviru
ad
rhinoviru
hrv
metapneumoviru
parainfluenza
viru
other
enteroviru
coronaviru
bocaviru
etc
major
acut
viral
ri
selflimit
progress
recoveri
aetiolog
treatment
whatsoev
occasion
exclud
certain
emerg
viru
diseas
coronaviru
sar
new
type
influenza
fundament
young
elderli
patient
underli
patholog
suscept
complic
see
clinic
condit
owe
sever
requir
special
care
current
specif
antivir
medicin
use
infect
influenza
viru
specif
clinic
situat
other
rsv
hrv
ad
although
certain
compound
eg
ribavirin
rsv
ad
pleconaril
hrv
shown
certain
activ
use
suffici
establish
consequ
acut
ri
everi
year
coincid
season
epidem
influenza
rsv
excess
demand
healthcar
system
result
increas
number
visit
overload
e
depart
increas
consumpt
antibiot
increas
perform
analyt
imag
test
base
sampl
respiratori
tract
basic
nasopharyng
aspir
lavag
lesser
extent
sampl
taken
nasal
andor
pharyng
brush
viral
transport
medium
current
number
procedur
avail
us
help
rapid
aetiolog
diagnosi
princip
acut
viral
ri
differ
techniqu
basic
split
two
group
antigen
detect
test
nucleic
acid
amplif
test
naat
direct
indirect
immunofluoresc
ict
commonli
use
test
other
immunoenzymat
membran
techniqu
frequent
use
past
push
background
use
possibl
detect
princip
rv
nonetheless
conduct
correctli
involv
certain
degre
difficulti
need
centrifug
make
extens
set
stain
correctli
need
use
fluoresc
microscop
view
subject
interpret
result
skill
observ
high
depend
sampl
qualiti
presenc
suffici
epitheli
cell
time
requir
obtain
result
min
mean
techniqu
use
increasingli
sparingli
initi
diagnosi
viral
ri
major
clinic
laboratori
use
classic
techniqu
improv
facilit
autom
process
perform
rapid
object
read
reaction
regard
techniqu
develop
detect
specif
virus
individu
other
increas
panel
virus
detect
apart
rsv
influenza
detect
ad
parainfluenza
viru
bocaviru
metapneumoviru
bacteria
pneumococcu
possibl
advantag
use
cost
effect
recent
report
although
still
numer
misgiv
regard
ict
test
reveal
reaction
colloid
gold
current
wide
use
simplic
requir
special
skill
rapid
implement
result
obtain
within
min
simpl
read
result
help
spread
use
procedur
use
rapidli
patient
bedsid
e
poct
less
sensit
unlik
latter
allow
wide
rang
rv
detect
major
exist
ict
devic
design
detect
rsv
andor
influenza
b
ict
great
deal
variabl
observ
result
depend
manufactur
sampl
use
much
better
sensit
result
observ
nasopharyng
aspiratelavag
sampl
taken
brush
time
diseas
evolut
sampl
taken
better
first
h
popul
appli
much
wors
result
adult
popul
children
gener
sensit
ict
techniqu
better
use
detect
rsv
diagnosi
influenza
molecular
techniqu
basic
pcr
highli
sensit
specif
replac
cell
cultur
refer
method
diagnosi
infect
caus
rv
also
make
possibl
detect
nonviabl
virus
possibl
isol
tradit
cell
cultur
gener
respons
time
excess
h
requir
specif
infrastructur
equip
well
specialis
personnel
limit
use
rapid
diagnosi
emerg
situat
nonetheless
recent
year
naat
develop
differ
quick
easi
format
loss
effici
compar
classic
molecular
procedur
minim
sampl
handl
dispens
sampl
individu
devic
extract
applic
detect
rv
perform
one
singl
piec
equip
true
viral
antigen
detect
test
develop
commerci
test
aim
detect
one
specif
viru
rsv
andor
influenza
evolv
multiplex
capabl
simultan
detect
major
possibl
virus
involv
process
result
obtent
time
min
minim
work
load
around
min
fig
propos
ration
work
flow
costeffect
algorithm
investig
respiratori
virus
rv
except
patient
includ
monitor
programm
eg
nation
influenza
monitor
network
b
except
special
situat
pregnanc
predispos
underli
diseas
etc
naat
perform
directli
c
naat
rv
rhinoviru
metapneumoviru
etc
may
ad
patient
high
risk
seriou
respiratori
ill
modifi
et
al
mean
current
possibl
use
poct
result
much
reliabl
obtain
viral
antigen
detect
test
gener
devic
make
possibl
process
limit
number
sampl
time
depend
platform
system
use
luminex
technolog
make
possibl
process
sampl
simultan
detect
differ
pathogen
virus
bacteria
obtain
result
h
need
use
three
differ
item
equip
process
hinder
use
rapid
test
regard
acut
viral
ri
find
case
rang
outpati
requir
rapid
diagnosi
specif
agent
occur
flu
pandem
pregnant
women
morbidli
obes
hospitalis
patient
seriou
underli
diseas
eg
oncohaematolog
condit
import
thing
rule
possibl
virus
involv
apart
particular
situat
comment
outbreak
sealedoff
institut
current
fairli
broad
consensu
nonus
test
outsid
hospit
environ
emerg
care
area
use
viral
antigen
detect
test
widespread
particularli
rsv
influenza
shown
reduc
prescript
antibiot
reduc
number
supplementari
diagnost
test
analyt
imag
even
case
rsv
lead
fals
sens
secur
distribut
patient
establish
isol
measur
result
may
time
counterproduct
possibl
associ
use
test
emerg
lower
consumpt
antibiot
patient
return
outpati
set
specif
case
viral
antigen
detect
test
influenza
viru
gener
demonstr
highli
defici
sensit
neg
predict
valu
owe
use
emerg
healthcar
beyond
specif
highrisk
case
patient
need
admit
call
question
fig
show
propos
algorithm
use
influenza
diagnost
test
epidem
period
gener
speak
consid
necessari
rule
influenza
viru
owe
patient
clinic
situat
order
start
treatment
earli
implement
prevent
measur
nosocomi
outbreak
influenza
better
implement
naat
directli
patient
requir
hospit
admiss
although
perform
influenza
diagnosi
test
recommend
hospitalis
patient
compat
clinic
symptom
case
empir
antivir
treatment
must
initi
soon
possibl
without
need
await
result
diagnost
test
owe
high
sensit
naat
capabl
detect
asymptomat
excret
low
viral
load
dubiou
clinic
signific
moreov
data
support
use
naat
evolutionari
control
patient
treatment
hand
even
though
multiplex
naat
entir
group
rv
use
poct
possess
high
level
sensit
specif
also
expens
limit
routin
use
normal
reserv
highli
specif
situat
critic
ill
patient
admit
icu
given
set
find
epidemiolog
situat
sever
clinic
symptom
clearli
need
establish
diagnost
algorithm
facilit
ration
effici
use
differ
diagnost
test
rv
fig
rapid
diagnosi
infect
pneumocysti
jirovecii
p
jirovecii
p
jirovecii
pathogen
fungu
reproduc
extracellularli
pulmonari
alveoli
mammal
lead
ill
immun
system
remain
unalt
nonetheless
situat
immunodepress
pneumocysti
capabl
prolifer
caus
sever
pneumonia
absenc
specif
treatment
case
colonis
pathogen
detect
p
jirovecii
respiratori
sampl
time
difficult
interpret
sinc
detect
necessarili
impli
agent
respons
diseas
pneumocysti
spp
biphas
life
cycl
two
highli
distinguish
morpholog
form
asexu
trophic
form
repres
haploid
trophozoit
prolif
state
fairli
abund
cystic
form
repres
reproduct
stage
less
abund
trophic
form
form
transmiss
infect
p
jirovecii
difficult
diagnos
given
noncultur
fungu
reason
exist
diagnost
test
classifi
rapid
perform
matter
minut
hour
essenti
group
stain
molecular
techniqu
fundament
pcr
either
convent
realtim
one
import
aspect
diagnosi
pneumocysti
infect
sampl
use
must
combin
sensit
test
employ
given
pneumocysti
live
alveolar
cell
pathogen
load
expect
greater
sampl
collect
alveolar
caviti
bronchoalveolar
lavag
bal
bronchoalveolar
aspir
sampl
sputum
either
induc
expector
bronchial
brush
even
sampl
upper
respiratori
tract
oral
wash
nasopharyng
aspir
nasal
swab
microscopi
techniqu
gener
less
sensit
pcr
henc
advis
alway
perform
bronchoalveolar
lavag
aspir
moreov
sampl
centrifug
stain
order
concentr
pneumocysti
respiratori
sampl
detect
includ
fluid
tracheal
suction
cell
materi
obtain
bronchial
brush
tissu
obtain
transtrach
biopsi
concern
stain
type
classic
use
diagnosi
infect
pneumocysti
describ
tabl
mean
methenaminesilv
stain
also
stain
fungi
cyst
pneumocysti
show
black
greenish
background
greatest
drawback
length
stain
sinc
normal
procedur
may
take
h
h
abbrevi
grocottgomori
method
reduc
min
perform
microwav
oven
kohcalcofluor
calcofluor
white
stain
perform
around
min
fluoresc
light
fungi
show
fluoresc
blue
modifi
toluidin
blue
stain
turn
pneumocysti
cyst
violet
around
min
order
observ
trophic
form
giemsa
stain
take
around
min
rapid
variant
giemsa
stain
diffquik
perform
around
min
gener
use
sampl
gener
contain
around
time
trophic
form
cyst
sensit
stain
may
greater
stain
cyst
pneumocysti
also
detect
around
min
mean
dif
use
monoclon
antibodi
target
surfac
glycoprotein
depend
monoclon
antibodi
select
possibl
specif
stain
cyst
form
microorgan
given
trophic
form
sensit
kit
stain
form
greater
antibodi
usual
mark
fluorescein
isothiocyan
mean
ultraviolet
light
microscop
wall
cyst
trophozoit
show
fluoresc
green
specif
microscop
techniqu
similar
sensit
dif
wide
use
molecular
techniqu
pcr
consid
around
time
sensit
microscopi
diagnosi
pneumonia
caus
p
jirovecii
sensit
pcr
enhanc
use
target
present
multipl
copi
pneumocysti
genom
codifi
gene
subunit
mitochondri
rrna
mitochondri
larg
subunit
rrna
major
surfac
glycoprotein
perform
nest
pcr
target
use
detect
pneumocysti
includ
intern
transcrib
spacer
ribosom
gene
cytoplasm
rrna
dihydrofol
reductas
thymidyl
synthas
high
sensit
pcr
capabl
detect
quantiti
lower
copiesl
sampl
mean
neg
pcr
text
pulmonari
sampl
bal
biopsi
serv
rule
involv
p
jirovecii
infect
fact
high
sensit
pcr
led
author
propos
diagnost
techniqu
respiratori
sampl
low
quantiti
pneumocysti
expect
sampl
immunodepress
patient
infect
hiv
noninvas
respiratori
sampl
induc
sputum
nasal
swab
etc
sinc
neg
result
avoid
need
resort
invas
techniqu
problem
noninvas
sampl
posit
result
may
detect
subclin
colonis
instead
acut
infect
joint
conduct
pcr
microscopi
induc
sputum
sampl
upper
respiratori
tract
suggest
posit
pcr
posit
microscopi
would
sign
infect
posit
pcr
neg
microscopi
would
repres
colonis
neg
pcr
result
would
exclud
infect
colonis
pneumocysti
drawback
convent
pcr
nest
pcr
lack
quantif
determin
would
reflect
fungal
load
present
could
thu
help
differenti
colonis
acut
infect
problem
overcom
realtim
quantit
pcr
nonetheless
clear
cutoff
point
distinguish
colonis
ill
yet
establish
gener
threshold
cycl
elev
initi
cycl
exponenti
phase
amplif
repres
low
fungal
load
possibl
suggest
colonis
infect
situat
posit
pcr
serolog
test
ad
detect
serum
betadglucan
even
without
specif
pneumocysti
increas
fungal
infect
supplement
posit
pcr
result
noninvas
respiratori
sampl
sputum
even
saliva
neg
predict
valu
betadglucan
assay
extrem
high
employ
patient
bronchoscopi
perform
slight
suspicion
infect
pneumocysti
reduct
dna
load
pneumocysti
mean
realtim
pcr
also
use
treatment
respons
control
uncommon
patient
infect
one
specif
genotyp
p
jirovecii
may
hinder
detect
specif
genotyp
quantif
quantit
pcr
molecular
techniqu
also
offer
altern
studi
infect
pneumocysti
includ
epidemiolog
persontoperson
transmiss
studi
multilocu
genotyp
even
approxim
resist
trimethoprimsulfamethoxazol
analys
mutat
codifi
gene
dihydroptero
synthas
dihydrofol
reductas
serolog
test
detect
antibodi
p
jirovecii
use
perform
epidemiolog
studi
diagnosi
acut
infect
gener
speak
rdt
use
diagnosi
mani
ri
facilit
better
approach
infect
aspect
current
rdt
detect
antigen
use
poct
case
major
nucleic
acid
amplif
test
turn
show
higher
percentag
specif
sensit
improv
term
simplic
sampl
process
interpret
result
would
seem
make
like
near
futur
use
nucleic
acid
amplif
test
poct
diagnosi
ri
becom
widespread
